In this 1h video, our experts will discuss Type-2 diabetes in relation to 2 patient case studies: when and how to use insulin/drug combinations considering GLP-1RA’s, SGLT2is, DPP4is and SU options.
Our experts will discuss:
- The use of PBS listed medications to treat patients diagnosed with T2D in line with recent T2D guidelines and treatment algorithms
- Individualised treatment options
- Dual and triple therapy/add on therapy options
- Guidance on adjusting treatment options as a patient’s T2D disease progresses considering tolerance, side effects, co-morbidities and the clinical goal
This program is supported by an independent and unrestricted educational grant by Sanofi.